Halman Aldubi Provident and Pension Funds Ltd. v. Teva Pharmaceutical Industries Limited et al, No. 20-cv-04660
In the Teva Pharmaceutical Industries securities case, Faruqi & Faruqi, LLP was appointed sole lead counsel. The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or ...
James M. Wilson, Jr., Robert W. Killorin at New York office
In re Bystolic Antitrust Litig., No. 20-cv-05735 (S.D.N.Y)
In the Bystolic case, Faruqi & Faruqi represents a proposed class of direct purchasers of Forest Laboratories' (now AbbVie) blood pressure drug, Bystolic. The complaint alleges that Forest entered into reverse payment agreements with several would-be ...
Joseph T. Lukens, Peter Kohn at Pennsylvania office
In re EpiPen Direct Purchaser Litig., No. 20-cv-0827 (D. Minn.)
In the EpiPen case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Mylan's EpiPen, an epinephrine auto-injector used to treat anaphylaxis (i.e. allergic reactions). The complaint alleges that Mylan ...
Joseph T. Lukens, Peter Kohn at Pennsylvania office
Luxury Retail Employees “No-Poach” Antitrust Litigation
Faruqi & Faruqi, LLP and The Joseph Saveri Law Firm have filed an antitrust class action complaint in the Federal Court of the Eastern District of New York alleging that Defendants Saks Incorporated, Saks & Company LLC, Saks Fifth Avenue LLC, Louis Vuitton ...
Innessa M. Huot at New York office
In re Seroquel XR (Extended Release Quetiapine Fumarate) Litig., No. 20-cv-01076 (D. Del.)
In the Seroquel case, Faruqi & Faruqi represents a proposed class of direct purchasers of AstraZeneca's Seroquel XR, a prescription drug treatment for schizophrenia, bipolar disorder, and depression. The complaint alleges that AstraZeneca entered into ...
Joseph T. Lukens, Peter Kohn at Pennsylvania office
Hesse et al. v. Godiva Chocolatiers, Inc. et al.
Faruqi & Faruqi, LLP is suing Godiva Chocolatier, Inc. for deceptively advertising its chocolate products as products of Belgium when they are made in the United States. The case has been brought on behalf of a proposed class of consumers who purchased ...
Timothy J. Peter at Pennsylvania office
In re Novartis and Par Antitrust Litig., No. 18-cv-04361 (S.D.N.Y.)
In the Exforge case, Faruqi & Farqui represents a pharmaceutical wholesaler and a proposed class of direct purchasers of the hypertension drug, Exforge. The complaint alleges that Novartis entered into a reverse payment agreement with Par to delay Par's ...
Joseph T. Lukens, Peter Kohn at Pennsylvania office
In re Zetia (Ezetimibe) Antitrust Litig., No. 18-md-02836 (E.D. Va.)
In the Zetia case, Faruqi & Faruqi represents a class of direct purchasers of Merck & Co.'s Zetia (ezetimibe), a drug used to treat high cholesterol. The case alleges that Merck entered into an unlawful reverse payment settlement with generic manufacturers ...
Joseph T. Lukens, Peter Kohn at Pennsylvania office
In re Tahoe Resources, Inc. Sec. Litig., No. 2:17-cv-01868 (D.Nev.)
In the Tahoe Resources securities case, Faruqi & Faruqi, LLP was appointed sole lead counsel. The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose material adverse information regarding ...
James M. Wilson, Jr., Robert W. Killorin at New York office
In re Intuniv Antitrust Litig., No. 16-cv-12653 (D. Mass.)
In the Intuniv case, Faruqi & Faruqi represents a class of direct purchasers of Shire's Intuniv (guanfacine), a prescription drug used to treat attention deficit hyperactivity disorder. The class also includes direct purchasers of generic versions of ...
Joseph T. Lukens, Peter Kohn at Pennsylvania office